We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $4.58B
1-Year Est. Return 43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$1.88B
Cap. Flow
+$1.03B
Cap. Flow %
22.6%
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$101M
2
JPM icon
JPMorgan Chase
JPM
+$79.2M
3
MCO icon
Moody's
MCO
+$58.8M
4
FITB
Fifth Third Bancorp
FITB
+$58.5M
5
LPLA icon
LPL Financial
LPLA
+$56M

Top Sells

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$68M
2
ACMR icon
ACM Research
ACMR
+$48.8M
3
CFG icon
Citizens Financial Group
CFG
+$47.1M
4
VSH icon
Vishay Intertechnology
VSH
+$46.3M
5
GS icon
Goldman Sachs
GS
+$44.7M

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.82%
2 Financials 20.39%
3 Healthcare 17.29%
4 Industrials 14.57%
5 Technology 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
351
AstraZeneca
AZN
$243B
– –
-80,130
Closed -$15.8M
BEAM icon
352
Beam Therapeutics
BEAM
$2.6B
– –
-15,518
Closed -$370K
BLTE
353
Belite Bio
BLTE
$7.38B
– –
-33,492
Closed -$5.34M
BNTX icon
354
BioNTech
BNTX
$24.7B
– –
-119,204
Closed -$10.6M
C icon
355
Citigroup
C
$231B
– –
-180,620
Closed -$20.5M
CFG icon
356
Citizens Financial Group
CFG
$29.2B
– –
-785,893
Closed -$47.1M
CNC icon
357
Centene
CNC
$31.6B
– –
-199,000
Closed -$6.52M
COGT icon
358
Cogent Biosciences
COGT
$5.93B
– –
-335,000
Closed -$12.9M
CRL icon
359
Charles River Laboratories
CRL
$13.3B
– –
-36,721
Closed -$6.33M
CTMX icon
360
CytomX Therapeutics
CTMX
$771M
– –
-550,000
Closed -$2.58M
CTSH icon
361
Cognizant
CTSH
$26.2B
– –
-548,800
Closed -$33.7M
DIOD icon
362
Diodes
DIOD
$4.15B
– –
-94,881
Closed -$6.48M
EWBC icon
363
East-West Bancorp
EWBC
$17.6B
– –
-36,913
Closed -$3.94M
FHN icon
364
First Horizon
FHN
$11.6B
– –
-399,537
Closed -$9.09M
FISV
365
Fiserv Inc
FISV
$25.9B
– –
-123,042
Closed -$6.87M
GDS icon
366
GDS Holdings
GDS
$6.49B
– –
-135,882
Closed -$5.47M
HUBB icon
367
Hubbell
HUBB
$24B
– –
-6,371
Closed -$3.13M
IBM icon
368
IBM
IBM
$226B
– –
-380
Closed -$92.1K
IMTX icon
369
Immatics
IMTX
$1.39B
– –
-780,967
Closed -$7.68M
INSP icon
370
Inspire Medical Systems
INSP
$1.92B
– –
-138,761
Closed -$7.16M
JBHT icon
371
JB Hunt Transport Services
JBHT
$25.2B
– –
-5,941
Closed -$1.26M
JKHY icon
372
Jack Henry & Associates
JKHY
$11.1B
– –
-128,056
Closed -$20.2M
KKR icon
373
KKR & Co
KKR
$93.4B
– –
-349,327
Closed -$32.3M
LECO icon
374
Lincoln Electric
LECO
$14.8B
– –
-1,674
Closed -$417K
LII icon
375
Lennox International
LII
$13B
– –
-496
Closed -$230K
13 14
15
16 17

Similar funds

CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
MR
Munich Reinsurance Munich $4.57B AUM 28.39% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.59B AUM 9.32% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $4.59B AUM 41.03% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

Longaeva Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.

  • Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
  • Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
  • Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
  • Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
  • Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
  • Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
  • Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.